High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: Association of high decoy receptor levels with glucocorticoid administration

Journal of Leukocyte Biology

Volumn 72, Issue 4, 2002, Pages 643-649

  Müller, Beat ^a   Peri, Giuseppe ^b   Doni, Andrea ^b   Perruchoud, André P ^a   Landmann, Regine ^a   Pasqualini, Fabio ^b   Mantovani, Alberto ^b,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Cytokines; Glucocorticoid hormones; Microbial infection; Severe sepsis

Indexed keywords

GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; COMPLEX FORMATION; CRITICAL ILLNESS; CYTOKINE RELEASE; DISEASE SEVERITY; ENDOTOXEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; SEPSIS; SYSTEMIC DISEASE;

ANTI-INFLAMMATORY AGENTS; CRITICAL ILLNESS; GLUCOCORTICOIDS; HUMANS; INTENSIVE CARE UNITS; PREDNISONE; RECEPTORS, INTERLEUKIN-1; SEPSIS;

BACTERIA (MICROORGANISMS);

EID: 0036826851     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Dinarello, C. A. (1996) Biological basis for IL-1 in disease. Blood 87, 2095-2147.
2. Mantovani, A., Dinarello, C., Ghezzi, P. (2000) Pharmacology of Cytokines, Oxford, UK, Oxford University Press.
3. O'Neill, L. A., Dinarello, C. A. (2000) The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today 21, 206-209.
4. Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., Mantovani, A. (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261, 472-475.
5. Colotta, F., Dower, S. K., Sims, J. E., Mantovani, A. (1994) The type II 'decoy' receptor: novel regulatory pathway for interleukin-1. Immunol. Today 15, 562-566.
6. Mantovani, A., Locati, M., Vecchi, A., Sozzani, S., Allavena, P. (2001) Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 22, 328-336.
7. Re, F., Sironi, M., Muzio, M., Matteucci, C., Introna, M., Orlando, S., Penton-Rol, G., Dower, S. K., Sims, J. E., Colotta, F., Mantovani, A. (1996) Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function. J. Exp. Med. 183, 1841-1850.
8. Lang, D., Knop, J., Wesche, H., Raffetseder, U., Kurrle, R., Boraschi, D., Martin, M. U. (1998) The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J. Immunol. 161, 6871-6877.
9. Malinowsky, D., Lundkvist, J., Layé, S., Bartfai, T. (1998) Interleukin-1 receptor accessory protein interacts with the type 11 interleukin-1 receptor. FEBS Lett. 429, 299-302.
10. Orlando, S., Sironi, M., Bianchi, G., Drummond, A. H., Boraschi, D., Yabes, D., Colotta, F., Mantovani, A. (1997) Role of the metalloproteases in the release of the IL-1 type II decoy receptor. J. Biol. Chem. 272, 31764-31769.
11. Orlando, S., Polentarutti, N., Mantovani, A. (2000) Selectivity release of the type II decoy IL-1 receptor. Cytokine 12, 1001-1006.
12. Colotta, F., Orlando, S., Fadlon, E. J., Sozzani, S., Matteucci, C., Mantovani, A. (1995) Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J. Exp. Med. 181, 2181-2188.
13. Re, F., Muzio, M., De Rossi, M., Polentarutti, N., Giri, J. G., Mantovani, A., Colotta, F. (1994) The type II "receptor" as a decoy target for IL-1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J. Exp. Med. 179, 739-743.
14. Colotta, F., Saccani, S., Giri, J. G., Dower, S. K., Sims, J. E., Introna, M., Mantovani, A. (1996) Regulated expression and release of the interleukin-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 156, 2534-2541.
15. Penton-Rol, G., Orlando, S., Polentarutti, N., Bernasconi, S., Muzio, M., Introna, M., Mantovani, A. (1999) Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts. J. Immunol. 162, 2931-2938.
16. Brown, E. A., Dare, H. A., Marsh, C. B., Wewers, M. D. (1996) The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 beta (IL-1 beta) and interleukin 1 receptor antagonist (IL-1ra). Cytokine 8, 828-836.
17. Yu, P. W., Schuler, L. A., Kehrli, M., Mattocks, L., Nonnecke, B. J., Czuprynski, C. J. (1997) Effects of dexamethasone treatment on IL-1 receptor mRNA levels in vivo. J. Leukoc. Biol. 62, 401-404.
18. Giri, J. G., Wells, J., Dower, S. K., McCall, C. E., Guzman, R. N., Slack, J., Bird, T. A., Shanebeck, K., Grabstein, K. H., Sims, J. E., Alderson, M. R. (1994) Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153, 5802-5809.
19. Pruitt, J. H., Welborn, M. B., Edwards, P. D., Harward, T. R., Seeger, J. W., Martin, T. D., Smith, C., Kenney, J. A., Wesdorf, R. I., Meijer, S., Cuesta, M. A., Abouhanze, A., Copeland III, E. M., Giri, J. G., Moldawer, L. L., Oldenburg, H. S. (1996) Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87, 3282-3288.
20. van Deuren, M., van der Ven-Jongekrijg, J., Vannier, E., van Dalen, R., Pesman, G., Bartelink, A. K. M., Dinarello, C. A., van der Meer, J. W. M. (1997) The pattern of interleukin-1b (IL-1b) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 90, 1101-1108.
21. Muller, B., Becker, K. L., Kranzlin, M., Schachinger, H., Huber, P. R., Nylen, E. S., Snider, R. H., White, J. C., Schmidt-Gayk, H., Zimmerli, W., Ritz, R. (2000) Disordered calcium homeostasis of sepsis: association with calcitonin precursors. Eur. J. Clin. Investig. 30, 823-831.
22. Muller, B., Becker, K. L., Sehachinger, H., Rickenbacher, P. R., Huber, P. R., Zimmerli, W., Ritz, R. (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit. Care Med. 28, 977-983.
23. Muller, B., White, J. C., Nylen, E. S., Snider, R. H., Becker, K. L., Habener, J. F. (2001) Ubiquitous expression of the calcitonin-1 gene in multiple tissues in response to sepsis. J. Clin. Endocrinol. Metab. 86, 396-404.
24. Knaus, W. A., Draper, E. A., Wagner, D. P., Zimmerman, J. E. (1985) APACHE II: a severity of disease classification system. Crit. Care Med. 13, 818-829.
25. Wagner, D. P., Knaus, W. A., Harrell, F. E., Zimmerman, J. E., Watts, C. (1994) Daily prognostic estimates for critically ill adults in intensive care units: results from a prospective, multicenter, inception cohort analysis. Crit. Care Med. 22, 1359-1372.
26. Castella, X., Artigas, A., Bion, J., Kari, A. (1995) A comparison of severity of illness scoring systems for intensive care unit patients: results of a multicenter, multinational study. The European/North American Severity Study Group. Crit. Care Med. 23, 1327-1335.
27. Young, L. S. (1995) Sepsis syndrome. In Mandell, Douglas and Bennett's Principles and Practice of infectious Diseases (G. L. Mandell, J. E, Bennett, R. Dolin, eds.), Philadelphia, PA, Churchill Livingstone, 690-705.
28. Muller, B., Peri, G., Doni, A., Torri, V., Landmann, R., Bottazzi, B., Mantovani, A. (2001) Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit. Care Med. 29, 1404-1407.
29. Novick, D., Kim, S. H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., Rubinstein, M. (1999) Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10, 127-136.
30. Kong, Y. Y., Boyle, W. J., Penninger, J. M. (2000) Osteoprotegerin ligand: a regulator of immune responses and bone physiology. Immunol. Today 21, 495-502.
31. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., Boyle, W. J. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
32. Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S. I., Yano, K., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., Kanno, T., Murakami, A. T., Morinaga, T., Higashio, K. (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139, 1329-1337.
33. Ashkenazi, A., Dixit, V. M. (1998) Death receptors: signaling and modulation. Science 281, 1305-1308.
34. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gumey, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., Goddard, A. D., Godowski, P., Ashkenazi, A. (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277, 818-821.
35. Jenkins, M., Keir, M., McCune, J. M. (2000) A membrane-bound Fas decoy receptor expressed by human thymocytes. J. Biol. Chem. 275, 7988-7993.
36. D'Amico, G., Frascaroli, G., Bianchi, G., Transidico, P., Doni, A., Vecchi, A., Sozzani, S., Allavena, P., Mantovani, A. (2000) Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat. Immunol. 1, 387-391.
37. Fernandez-Botran, R., Chilton, P. M., Ma, Y. (1996) Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy. In Advances in Immunology (F. J. Dixon, ed.), San Diego, CA, Academic, 269-336.
38. Heaney, M. L., Golde, D. V. (1996) Soluble cytokine receptors. Blood 87, 847-857.
39. Barak, V., Nisman, B., Polliack, A., Vannier, E., Dinarello, C. A. (1998) Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia. Eur. Cytokine Netw. 9, 33-39.
40. van der Poll, T., de Waal Malefyt, R., Coyle, S. M., Lowry, S. F. (1997) Anti-inflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J. Infect. Dis. 175, 118-122.
41. Vannier, E., Kaser, A., Atkins, M. B., Fantuzzi, G., Dinarello, C. A., Mier, J. W., Tilg, H. (1999) Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy. Eur. Cytokine Netw. 10, 37-42.
42. Colotta, F., Re, F., Muzio, M., Polentarutti, N., Minty, A., Caput, D., Ferrara, P., Mantovani, A. (1994) IL-13 induces expression and release of the IL-1 decoy receptor in human polymorphonuclear cells. J. Biol. Chem. 269, 12403-12406.
43. Tam, F. W., Smith, J., Karkar, A. M., Pusey, C. D., Rees, A. J. (1997) Interleukin-4 ameliorates experimental glomerulonephritis and up- regulates glomerular gene expression of IL-1 decoy receptor. Kidney Int. 52, 1224-1231.
44. Dickensheets, H. L., Donnelly, R. P. (1997) IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes. J. Immunol. 159, 6226-6233.
45. Daun, J. M., Ball, R. W., Burger, H. R., Cannon, J. G. (1999) Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in vivo. J. Leukoc. Biol. 65, 863-866.
46. Dentener, M. A., Creutzberg, E. C., Schols, A. M., Mantovani, A., van't Veer, C., Buurman, W. A., Wouters, E. F. (2001) Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax 56, 721-726.